Crossref journal-article
Springer Science and Business Media LLC
Nature (297)
Bibliography

Seoane, J., Le, H.-V., & Massagué, J. (2002). Myc suppression of the p21Cip1 Cdk inhibitor influences the outcome of the p53 response to DNA damage. Nature, 419(6908), 729–734.

Authors 3
  1. Joan Seoane (first)
  2. Hong-Van Le (additional)
  3. Joan Massagué (additional)
References 30 Referenced 528
  1. Vogelstein, B., Lane, D. & Levine, A. J. Surfing the p53 network. Nature 408, 307–310 (2000) (10.1038/35042675) / Nature by B Vogelstein (2000)
  2. Vousden, K. H. & Lu, X. Live or let die: the cell's response to p53. Nature Rev. Cancer 2, 594–604 (2002) (10.1038/nrc864) / Nature Rev. Cancer by KH Vousden (2002)
  3. Lane, D. How cells choose to die. Nature 414, 25–27 (2001) (10.1038/35102132) / Nature by D Lane (2001)
  4. Grandori, C., Cowley, S. M., James, L. P. & Eisenman, R. N. The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu. Rev. Cell Dev. Biol. 16, 653–699 (2000) (10.1146/annurev.cellbio.16.1.653) / Annu. Rev. Cell Dev. Biol. by C Grandori (2000)
  5. Alexandrow, M. G., Kawabata, M., Aakre, M. & Moses, H. L. Overexpression of the c-Myc oncoprotein blocks the growth-inhibitory response but is required for the mitogenic effects of transforming growth factor beta 1. Proc. Natl Acad. Sci. USA 92, 3239–3243 (1995) (10.1073/pnas.92.8.3239) / Proc. Natl Acad. Sci. USA by MG Alexandrow (1995)
  6. Mitchell, K. O. & El-Deiry, W. S. Overexpression of c-Myc inhibits p21WAF1/CIP1 expression and induces S-phase entry in 12-O-tetradecanoylphorbol-13-acetate (TPA)-sensitive human cancer cells. Cell Growth Differ. 10, 223–230 (1999) / Cell Growth Differ. by KO Mitchell (1999)
  7. Claassen, G. F. & Hann, S. R. A role for transcriptional repression of p21CIP1 by c-Myc in overcoming transforming growth factor-β-induced cell-cycle arrest. Proc. Natl Acad. Sci. USA 97, 9498–9503 (2000) (10.1073/pnas.150006697) / Proc. Natl Acad. Sci. USA by GF Claassen (2000)
  8. Warner, B. J., Blain, S. W., Seoane, J. & Massague, J. Myc downregulation by transforming growth factor β required for activation of the p15Ink4B G1 arrest pathway. Mol. Cell. Biol. 19, 5913–5922 (1999) (10.1128/MCB.19.9.5913) / Mol. Cell. Biol. by BJ Warner (1999)
  9. Datto, M. B., Yu, Y. & Wang, X.-F. Functional analysis of the transforming growth factor β responsive elements in WAF1/Cip1/p21 promoter. J. Biol. Chem. 270, 28623–28628 (1995) (10.1074/jbc.270.48.28623) / J. Biol. Chem. by MB Datto (1995)
  10. El-Deiry, W. S. et al. WAF1, a potential mediator of p53 tumour suppression. Cell 75, 817–825 (1993) (10.1016/0092-8674(93)90500-P) / Cell by WS El-Deiry (1993)
  11. Zeng, Y. X. & el-Deiry, W. S. Regulation of p21WAF1/CIP1 expression by p53-independent pathways. Oncogene 12, 1557–1564 (1996) / Oncogene by YX Zeng (1996)
  12. Massague, J., Blain, S. W. & Lo, R. S. TGFβ signaling in growth control, cancer, and heritable disorders. Cell 103, 295–309 (2000) (10.1016/S0092-8674(00)00121-5) / Cell by J Massague (2000)
  13. Zeng, Y. X., Somasundaram, K. & el-Deiry, W. S. AP2 inhibits cancer cell growth and activates p21WAF1/CIP1 expression. Nature Genet. 15, 78–82 (1997) (10.1038/ng0197-78) / Nature Genet. by YX Zeng (1997)
  14. Biggs, J. R., Kudlow, J. E. & Kraft, A. S. The role of the transcription factor Sp1 in regulating the expression of the WAF1/CIP1 gene in U937 leukemic cells. J. Biol. Chem. 271, 901–906 (1996) (10.1074/jbc.271.2.901) / J. Biol. Chem. by JR Biggs (1996)
  15. Waldman, T., Kinzler, K. W. & Vogelstein, B. p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res. 55, 5187–5190 (1995) / Cancer Res. by T Waldman (1995)
  16. Bunz, F. et al. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282, 1497–1501 (1998) (10.1126/science.282.5393.1497) / Science by F Bunz (1998)
  17. Gewirtz, D. A. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem. Pharmacol. 57, 727–741 (1999) (10.1016/S0006-2952(98)00307-4) / Biochem. Pharmacol. by DA Gewirtz (1999)
  18. Resnick-Silverman, L., St Clair, S., Maurer, M., Zhao, K. & Manfredi, J. J. Identification of a novel class of genomic DNA-binding sites suggests a mechanism for selectivity in target gene activation by the tumour suppressor protein p53. Genes Dev. 12, 2102–2107 (1998) (10.1101/gad.12.14.2102) / Genes Dev. by L Resnick-Silverman (1998)
  19. Zawel, L. et al. Human Smad3 and Smad4 are sequence-specific transcription activators. Mol. Cell 1, 611–617 (1998) (10.1016/S1097-2765(00)80061-1) / Mol. Cell by L Zawel (1998)
  20. Staller, P. et al. Repression of p15INK4b expression by Myc through association with Miz-1. Nature Cell Biol. 3, 392–399 (2001) (10.1038/35070076) / Nature Cell Biol. by P Staller (2001)
  21. Seoane, J. et al. TGFβ influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b. Nature Cell Biol. 3, 400–408 (2001) (10.1038/35070086) / Nature Cell Biol. by J Seoane (2001)
  22. Ziegelbauer, J. et al. Transcription factor MIZ-1 is regulated via microtubule association. Mol. Cell 8, 339–349 (2001) (10.1016/S1097-2765(01)00313-6) / Mol. Cell by J Ziegelbauer (2001)
  23. Zindy, F. et al. Myc signaling via the ARF tumour suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev. 12, 2424–2433 (1998) (10.1101/gad.12.15.2424) / Genes Dev. by F Zindy (1998)
  24. Burri, N. et al. Methylation silencing and mutations of the p14ARF and p16INK4a genes in colon cancer. Lab. Invest. 81, 217–229 (2001) (10.1038/labinvest.3780230) / Lab. Invest. by N Burri (2001)
  25. Polyak, K., Waldman, T., He, T. C., Kinzler, K. W. & Vogelstein, B. Genetic determinants of p53-induced apoptosis and growth arrest. Genes Dev. 10, 1945–1952 (1996) (10.1101/gad.10.15.1945) / Genes Dev. by K Polyak (1996)
  26. Reynisdottir, I., Polyak, K., Iavarone, A. & Massague, J. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β. Genes Dev. 9, 1831–1845 (1995) (10.1101/gad.9.15.1831) / Genes Dev. by I Reynisdottir (1995)
  27. Peukert, K. et al. An alternative pathway for gene regulation by Myc. EMBO J. 16, 5672–5686 (1997) (10.1093/emboj/16.18.5672) / EMBO J. by K Peukert (1997)
  28. Li, J. M., Nichols, M. A., Chandrasekharan, S., Xiong, Y. & Wang, X. F. Transforming growth factor beta activates the promoter of cyclin-dependent kinase inhibitor p15INK4B through an Sp1 consensus site. J. Biol. Chem. 270, 26750–26753 (1995) (10.1074/jbc.270.45.26750) / J. Biol. Chem. by JM Li (1995)
  29. Hata, A. et al. OAZ uses distinct DNA- and protein-binding zinc fingers in separate BMP-Smad and Olf signaling pathways. Cell 100, 229–240 (2000) (10.1016/S0092-8674(00)81561-5) / Cell by A Hata (2000)
  30. Shang, Y., Hu, X., DiRenzo, J., Lazar, M. A. & Brown, M. Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103, 843–852 (2000) (10.1016/S0092-8674(00)00188-4) / Cell by Y Shang (2000)
Dates
Type When
Created 22 years, 10 months ago (Oct. 16, 2002, 3:12 p.m.)
Deposited 2 years, 3 months ago (May 18, 2023, 2:10 p.m.)
Indexed 1 month ago (July 26, 2025, 5:07 a.m.)
Issued 22 years, 10 months ago (Oct. 1, 2002)
Published 22 years, 10 months ago (Oct. 1, 2002)
Published Online 22 years, 10 months ago (Oct. 2, 2002)
Published Print 22 years, 10 months ago (Oct. 1, 2002)
Funders 0

None

@article{Seoane_2002, title={Myc suppression of the p21Cip1 Cdk inhibitor influences the outcome of the p53 response to DNA damage}, volume={419}, ISSN={1476-4687}, url={http://dx.doi.org/10.1038/nature01119}, DOI={10.1038/nature01119}, number={6908}, journal={Nature}, publisher={Springer Science and Business Media LLC}, author={Seoane, Joan and Le, Hong-Van and Massagué, Joan}, year={2002}, month=oct, pages={729–734} }